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o r i g i n a l a r t i c l e
Outpatient Antibiotic Prescription Trends in the United States:
A National Cohort Study
Michael J. Durkin, MD, MPH;1 S. Reza Jafarzadeh, DVM, MPVM, PhD;2 Kevin Hsueh, MD;1 Ya Haddy Sallah, MPH;1
Kiraat D. Munshi, PhD;3 Rochelle R. Henderson, PhD;3 Victoria J. Fraser, MD1 for the CDC Prevention Epicenters
objective. To characterize trends in outpatient antibiotic prescriptions in the United States.
design. Retrospective ecological and temporal trend study evaluating outpatient antibiotic prescriptions from 2013 to 2015.
setting. National administrative claims data from a pharmacy beneﬁts manager PARTICIPANTS. Prescription pharmacy beneﬁciaries
from Express Scripts Holding Company.
measurements. Annual and seasonal percent change in antibiotic prescriptions.
results. Approximately 98 million outpatient antibiotic prescriptions were ﬁlled by 39 million insurance beneﬁciaries during the 3-year
study period. The most commonly prescribed antibiotics were azithromycin, amoxicillin, amoxicillin/clavulanate, ciproﬂoxacin, and cepha-
lexin. No signiﬁcant changes in individual or overall annual antibiotic prescribing rates were found during the study period. Signiﬁcant seasonal
variation was observed, with antibiotics being 42%more likely to be prescribed during February than September (peak-to-trough ratio [PTTR],
1.42; 95% conﬁdence interval [CI], 1.39–1.61). Similar seasonal trends were found for azithromycin (PTTR, 2.46; 95% CI, 2.44–3.47),
amoxicillin (PTTR, 1.52; 95% CI, 1.42–1.89), and amoxicillin/clavulanate (PTTR, 1.78; 95% CI, 1.68–2.29).
conclusions. This study demonstrates that annual national outpatient antibiotic prescribing practices remained unchanged during our
study period. Furthermore, seasonal peaks in antibiotics generally used to treat viral upper respiratory tract infections remained unchanged
during cold and inﬂuenza season. These results suggest that inappropriate prescribing of antibiotics remains widespread, despite the concurrent
release of several guideline-based best practices intended to reduce inappropriate antibiotic consumption; however, further research linking
national outpatient antibiotic prescriptions to associated medical conditions is needed to conﬁrm these ﬁndings.
Infect Control Hosp Epidemiol 2018;39:584–589
The selective pressures of both inpatient and outpatient
antibiotic use have contributed to the evolution of increasingly
drug-resistant bacteria. The Centers for Disease Control and
Prevention (CDC) recognizes multidrug-resistant organisms
and infections, such as Clostridium difﬁcile infection (CDI) and
carbapenem-resistant Enterobacteriaceae (CRE), as urgent
threats to the US healthcare system.1 It is estimated that the CDI
alone causes 2,500,000 infections, 14,000 deaths, and $1 billon
in excess medical costs per year. Furthermore, the ﬁrst
pan-resistant CRE isolate in the United States, mcr-1, was
recently identiﬁed, ushering us into the “post-antibiotic era.”2
Truly, more responsible management of antibiotic utilization is
urgently needed to limit the development of antibiotic resistance.
Signiﬁcant scrutiny has been placed on antibiotic utilization
in hospitals. The CDC has proposed comparing and
monitoring antibiotic utilization among hospitals using the
standardized antimicrobial administration ratio.3 Further-
more, the Centers for Medicare and Medicaid Services has
proposed a rule requiring all acute-care hospitals to have
formal antibiotic stewardship programs to reduce
inappropriate antibiotic use.4
Despite aggressive national action on inpatient antibiotic
use, outpatient antibiotic utilization rates and appropriateness
remains poorly studied. Conservative estimates suggest that up
to 30% of outpatient antibiotic use among medical providers
may be inappropriate.5 Mistreatment of viral respiratory tract
conditions with antibiotics is particular concerning. For
example, in one study, >70% of adult patients with pharyngitis
were given an antibiotic prescription, while only 18% met
treatment criteria for streptococcal pharyngitis.5 Sinusitis, also
often a viral condition, was the number 1 medical condition
associated with antibiotic prescriptions in a large national
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data set.5 Furthermore, children receive excessive antibiotics
when inﬂuenza is circulating in the community.6 The objective
of our study was to evaluate outpatient antibiotic prescription
patterns over time, and in particular, to assess the presence of
seasonal variation in use of common antibiotics. We hypo-
thesize that the annual antibiotic prescription rate has declined
annually and that the most common antibiotics will exhibit
seasonal variation, with higher antibiotic prescription rates
during the winter months corresponding to the distribution of
upper respiratory viral illnesses, particularly inﬂuenza.
methods
Study Design and Data Source
This study is an ecological and temporal trend study involving
retrospective analysis of outpatient antibiotic prescriptions
from deidentiﬁed administrative claims data for the period
between January 1, 2013, and December 31, 2015. Outpatient
antibiotic prescription data were obtained for a sample of
insured members whose pharmacy beneﬁts were managed by a
large pharmacy beneﬁt management company, Express Scripts
Holding Company.
Study Variables
Antibiotic utilization was initially evaluated on an annual basis
for the 3-year period from 2013 to 2015. All systemic
outpatient antibiotics were summed per calendar year. Elig-
ibility was not controlled for during the study period. Hence,
prescription rates per 1,000 beneﬁciaries were calculated using
midpoint values of beneﬁciaries for each calendar year.
Antibiotic costs were calculated by summing individual mem-
bers’ health insurance plan costs and out-of-pocket expenses.
Costs per prescription were extracted and summed per
calendar year and calculated as costs per 1,000 beneﬁciaries.
Data included total number of prescriptions, total number of
prescribers, antibiotic name, number of antibiotic pills
prescribed, date of prescription, cost of antibiotic prescription,
and geographic location of prescriber by state. Prescription
claims for members with missing or duplicate information were
removed. In addition, reversed (unﬁlled) prescription claims
were excluded from the analysis.
Analysis
Monthly prescription rates for all antibiotics were plotted for
each of the 3 years examined in this study to visualize the
seasonal variation. The 5 most commonly prescribed anti-
biotics in the database were plotted and assessed in a similar
fashion. A seasonal pattern in health outcomes is often referred
to events that happen with some regularity at ﬁxed times or
dates, or in distinct climatic periods; however, seasonality may
not be speciﬁcally regular in its amplitude, timing, or shape.7
Seasonal variations in prescription counts were assessed
by ﬁtting log-linear Poisson regression models to monthly
data. The magnitude of seasonal variations was quantiﬁed by
peak-to-trough ratio (PTTR), which is interpreted as a relative
risk with the trough month as the reference level.8 Unlike the
estimators based on geometrical models that assume a single
peak 6 months subsequent to a trough, the estimator based on
unadjusted Poisson regression provides ﬂexibility in the pat-
tern of seasonal variation and can adjust for the secular
trend bias.
Overall temporal trends in antibiotics prescriptions were
quantiﬁed and expressed as annual percent change through
ﬁtting linear regression models with autoregressive integrated
moving average (ARIMA) errors to the natural logarithm of
monthly rates.9 This allows accounting for the correlation of
model errors over time (ie, autocorrelation) during the study
period.10 Analyses for seasonality and trends were performed
in R version 3.2.4 (R Foundation for Statistical Computing,
Vienna, Austria). All other statistics including descriptive
analyses were computed using SAS version 9.4 (SAS Institute,
Cary, NC). The Washington University Ofﬁce of Human
Research Protection approved this study.
results
Annual Antibiotic Prescription Trend
Approximately 98 million antibiotic prescriptions were ﬁlled
during the 3-year study period from a sample of nearly 39
million insured members (Table 1). The mean number of
prescriptions per 1,000 beneﬁciaries was 826 between 2013
and 2015, and this number ranged from 830 to 849 annually.
There was a decrease in the antibiotic prescription rate
between 2013 and 2014, followed by an increase in 2015.
Although the average individual antibiotic costs per beneﬁciary
were modest ($23 dollars per year), the overall costs in the
cohort were enormous in our cohort, representing 840 million
to nearly $1 billion annually.
The 5 most commonly prescribed antibiotics were azi-
thromycin, amoxicillin, amoxicillin/clavulanate, ciproﬂoxacin,
and cephalexin (Table 2). Linear regression estimates of
temporal trends expressed as annual percent change in
prescriptions demonstrated no statistically signiﬁcant changes
in prescribing rates during the 36-month study period for all
antibiotics as well as the top 5 most commonly prescribed
antibiotics (Table 2).
table 1. Numbers and Rates of Outpatient Antibiotic Prescriptions
Within the Express Scripts Database, 2013 to 2015.
Year
No. of
Prescriptions,
Millions
No. of
Prescriptions
per 1,000
Beneﬁciaries
Total Drug
Costs, $
Cost per 1,000
Beneﬁciaries, $
2013 29.95 829 902,658,788 24,994
2014 28.75 799 804,029,460 22,331
2015 28.98 851 764,731,899 22,460
Total 87.68 826 2,471,420,147 23,278
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Seasonal Variation in Antibiotic Prescriptions
The overall antibiotic prescription rate varied signiﬁcantly by
month (Figure 1) with a seasonal peak observed in February that
was 42% higher than the trough in September (PTTR, 1.42; 95%
conﬁdence interval [CI], 1.39–1.61). The top 3 antibiotics
prescribed (azithromycin, amoxicillin, and amoxicillin/clavula-
nate) had similar winter-peaking trends (Table 3 and Figure 1).
For example, usage of azithromycin, the most commonly
prescribed medication in this study, increased by 146% in Feb-
ruary compared to August (Table 3). Seasonal trends for the less
commonly prescribed antibiotic medications, ciproﬂoxacin, and
cephalexin, however, were reversed, with the highest prescribing
month in the summer and the lowest prescribing month in the
winter (Table 3 and Figure 1). Furthermore, the seasonal
variation in the usage of ciproﬂoxacin and cephalexin was less
pronounced; these medications had 15% and 22% increases in
the peak month of August compared to the trough month of
January, respectively (Table 3 and Figure 1).
discussion
Annual antibiotic prescribing rates remained unchanged over
the course of our 3-year cohort study of more than 30 million
insured members. These ﬁndings are surprising given the
increasing pressure from multiple professional societies to
reduce inappropriate prescribing practices. Since the beginning
of our study in 2013, the American Board of Internal Medicine
(ABIM) Foundation, in conjunction with a number of medical
professional societies, has released practical recommendations
in their “Choosing Wisely” campaign to reduce inappropriate
antibiotic prescribing practices for the following conditions:
asymptomatic bacteriuria, suspected viral upper respiratory
tract infections, stasis dermatitis for lower extremities,
antibiotic prophylaxis for mitral valve prolapse, antibiotics for
uncomplicated skin and soft-tissue infections after successful
incision and drainage, inﬂamed epidermal cysts, uncompli-
cated acute tympanostomy tube otorrhea, and uncomplicated
acute external otitis.11 The Center for Disease Control and
Prevention (CDC) also provides educational resources for
healthcare professionals, policy makers, and the public to
reduce inappropriate antibiotic use through the longstanding
“Get Smart: Know When Antibiotics Work” program.12
The lack of any apparent change in utilization over the
course of this study may support the ﬁndings of other studies
suggesting that professional guidelines may not be the most
effective form of inﬂuencing provider actions. Suda et al
demonstrated a modest 2.6% decline in antibiotic prescrip-
tions nationally in the United States between 2006 and 2010;
however, only stratiﬁed statistical analyses were performed to
evaluate this trend.13 Longer longitudinal data of primary care
providers from the United Kingdom between 1995 and 2011
have shown mixed results from best practice guidelines alone.
During this period, prescriptions for sore throats declined
from 77% to 62% and prescriptions for otitis media increasing
from 77% in to 85%.14 Similar ﬁndings have been observed
for cesarean sections,15 management of pediatric femoral
fractures,16 and thrombophilia screening.17 Clearly, we need
more effective methods to disseminate and implement
evidence-based guidelines for healthcare providers.
Several outpatient antimicrobial stewardship interventions
have led to improved antibiotic utilization. Interventions as
simple as posters placed in a patient waiting rooms can reduce
antibiotic prescribing for acute respiratory tract infections.18
Some examples of more detailed interventions include
antibiotic prescription benchmarking, audit and feedback, and
education sessions.19,20
Seasonal variation in antibiotic prescribing has been pre-
viously reported in the United States,13,21 Europe,22,23
Canada,24 and Israel.25 In each of these studies, overall
antibiotic use was higher during the winter months. The rate of
increase ranged between 21% and 42%, with our study at the
top of the range. The higher rate of macrolide antibiotic
prescribing during the winter months has been linked to
inappropriate antibiotic prescribing for viral infections.23–25
Previous investigators have suggested that spikes in antibiotic
prescriptions during winter months may represent inap-
propriate treatment for viral conditions, which tend to occur
more frequently during winter months.13,21,26–28
table 2. Estimates of Average Antibiotic Use Annual Percent
Change for Common Antibiotic Prescriptions Within the Express
Scripts Database, 2013 to 2015.
Antibiotics
Average No. of Antibiotic
Prescriptions per 1,000
Beneﬁciaries
Annual Change, %
(95% CI)
All antibiotics 826 − 1.18 (−8.07 to 6.21)
Azithromycin 443 − 4.19 (−15.31 to 8.39)
Amoxicillin 433 1.87 (−5.27 to 9.56)
Amoxicillin/
Clavulanate
242 4.05 (−1.61 to 10.04)
Ciproﬂoxacin 173 −2.26 (−4.73 to 0.27)
Cephalexin 186 1.07 (−1.94 to 4.18)
table 3. Estimates of Seasonal Variation in Antibiotic Prescriptions
Within the Express Scripts Database Expressed as Peak-to-Trough
Ratios, 2013 to 2015.
Antibiotic
Peak-to-Trough
Ratio (95% CI)a
Peak
Month
Trough/Reference
Month
All antibiotics 1.42 (1.39–1.61) February September
Azithromycin 2.46 (2.44–3.47) February August
Amoxicillin 1.52 (1.42–1.89) February August
Amoxicillin/
Clavulanate
1.78 (1.68–2.29) February August
Ciproﬂoxacin 1.15 (1.15–1.22) August January
Cephalexin 1.22 (1.20–1.24) August January
aConﬁdence interval does not include 1. Estimated peak and trough
months were calculated via regression models and slightly vary from
actual antibiotic prescription count data.
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ﬁgure 1. Monthly variation of rate of outpatient antibiotic use overall and stratiﬁed by the top 5 antibiotics. NOTE. Rx, prescription.
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Many common bacterial infections also exhibit seasonal
variation. For example, bloodstream infections,29,30 urinary tract
infections,31 peritoneal dialysis infections,32 skin and soft-tissue
infections,33 and surgical site infections34–36 are all more
common during the summer months. However, Streptococcus
pneumoniae, community-acquired pneumonia, and methicillin-
resistant Staphylococcus aureus pneumonia tend to be more
common during the winter months.37–40 Therefore, at least some
of the peak in antibiotic prescribing is likely related to appropriate
treatment of bacterial conditions. Not surprisingly, ciproﬂoxacin
and cephalexin, common antibiotics used for urinary tract
infections and skin and soft-tissue infections, were associated
with higher antibiotic use during the summer months in our
study. These ﬁndings are novel and have not been described
previously in the literature. Furthermore, these ﬁndings also
highlight that precautions must be taken not to overgeneralize
when analyzing antibiotic use. For example, moxiﬂoxacin and
ciproﬂoxacin are both ﬂuoroquinolone antibiotics; however,
moxiﬂoxacin is more frequently used for respiratory tract infec-
tions, while ciproﬂoxacin is used primarily for urinary tract
infections. Classifying these 2 agents together could misrepresent
the different seasonal patterns in the prescriptions of these
medications and the infections they are used to treat.
This study has several limitations. First, this cohort repre-
sents only insured patients, so the results may not be general-
izable to the entire US population, including uninsured
individuals. However, our results were similar to those of
larger studies estimating antibiotic prescribing for the entire
United States.13 Second, medications are captured only when
the claims are processed, so prescription claims that are not
processed (eg, during instances when individuals chose to pay
for inexpensive antibiotics out-of-pocket without using their
insurance) were not captured. Therefore, our data likely
underestimates overall antibiotic utilization in our cohort.
Third, our analysis does not include any microbiology or
medical claims data; thus, we were unable to adequately assess
the appropriateness of each antibiotic prescribed or the
comorbidities of patients who received antibiotics. For exam-
ple, some antibiotic prescriptions written during the winter
months were likely appropriate for conditions like Strepto-
coccal and Staphylococcal pneumonia, which are more
common during winter months as well. Fourth, the data set
that we used did not contain information at an individual
patient level, so we were unable to determine whether our data
contained a large number of antibiotic prescriptions for a few
patients or a few antibiotics for a large number of patients.
Similarly, because our analysis was limited to prescription
counts, we did not evaluate differences in antibiotic prescrip-
tion dose or duration of therapy in this analysis. Sixth, we did
not compare inﬂuenza-like illness and antiviral prescription
rates in our study. Although this would have been a nice
additional evaluation, these are typically evaluated weekly
(rather than monthly) and span calendar years, making com-
parisons using our data challenging. Additional analyses
should be performed to more rigorously evaluate the
relationships among antiviral prescriptions, inﬂuenza-like ill-
nesses, and antibiotic prescriptions.
In conclusion, there were no appreciable changes in overall
antibiotic use over the 3-year study period in our cohort of
more than 30 million privately insured individuals in the
United States, despite the concurrent release of a number of
guideline-based best practices designed to reduce inappropri-
ate antibiotic consumption. Furthermore, we identiﬁed
signiﬁcant seasonal variation in antibiotic prescribing. Certain
agents frequently associated with inappropriate management
of upper respiratory tract infections, such as azithromycin,
were prescribed at a higher rate during the winter months.
Additional work is needed to better link antibiotic prescrip-
tions to indications to better quantify and trend inappropriate
antibiotic prescribing practices. However, in our opinion,
additional interventions, beyond guidelines and educational
materials, will be required to substantially improve antibiotic
prescribing at a national level.
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